犬尿氨酸对人类骨代谢的不利影响
该病例对照研究收集72例髋部手术患者的骨髓样本,发现骨髓犬尿氨酸水平随年龄增长而升高,且与脆性髋骨折风险增加、骨量降低及骨吸收标志物升高相关,提示犬尿氨酸可能通过增加骨吸收参与老年骨脆性。
要点
- 骨髓犬尿氨酸水平与年龄正相关
- 脆性髋骨折患者骨髓犬尿氨酸水平较无骨折者高39.7%
- 骨髓犬尿氨酸水平与骨吸收标志物TRAP5b和RANKL正相关
核心结论
- 衰老过程中犬尿氨酸水平升高可能通过增加骨吸收导致老年骨脆性。
研究设计与样本
- 病例对照研究,纳入72例髋部手术患者,其中脆性髋骨折27例,其他原因45例。
主要发现
- 年龄与骨髓犬尿氨酸水平呈正相关。
- 调整混杂因素后,脆性髋骨折患者骨髓犬尿氨酸水平比无骨折者高39.7%。
- 骨髓犬尿氨酸水平每增加1个标准差,脆性髋骨折的OR为3.80。
- 骨髓犬尿氨酸水平与全股骨骨量呈负相关。
- 较高的犬尿氨酸浓度与骨髓血浆中较高的TRAP-5b和RANKL水平显著相关,但与BSALP和OPG水平无关。
关键数值与推荐
- 骨髓犬尿氨酸水平每增加1个标准差,脆性髋骨折的OR为3.80。
- 脆性髋骨折患者骨髓犬尿氨酸水平较无骨折者高39.7%。
临床怎么用
- 骨髓犬尿氨酸水平可能作为评估老年骨脆性风险的生物标志物。
- 针对犬尿氨酸通路的干预或有助于预防年龄相关骨丢失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Studies in aged mice support a role for kynurenine, a tryptophan metabolite, in age-induced bone loss; however, the role of kynurenine in human bone metabolism is not well understood. OBJECTIVE: To assess whether the kynurenine level in bone marrow (BM) aspirates, directly reflecting the bone microenvironment, is associated with osteoporosis-related phenotypes and bone biochemical markers. DESIGN AND SETTING: A case-control study conducted in a clinical unit. PARTICIPANTS AND MAIN OUTCOME MEASURES: BM samples were collected from 72 patients at the time of hip surgery for either fragility hip fracture (HF) (n = 27) or for other causes (n = 45). In these samples, kynurenine was measured by liquid chromatography-tandem mass spectrometry, and the levels of tartrate-resistant acid phosphatase 5b (TRAP5b), bone-specific alkaline phosphatase (BSALP), receptor activator of nuclear factor-κB ligand (RANKL), and osteoprotegerin (OPG) were measured by immunoassay. RESULTS: Age was positively correlated with BM kynurenine level. After adjustment for confounders, subjects with fragility HF had a 39.7% higher BM kynurenine level than those without, and the OR per SD increment in BM kynurenine level for fragility HF was 3.80. The BM kynurenine level was inversely associated with bone mass at the total femur. Higher kynurenine concentrations were significantly associated with higher TRAP-5b and RANKL levels, but not with BSALP and OPG levels, in BM plasma. CONCLUSION: These results suggest that increased kynurenine levels during aging may contribute to the bone fragility seen in the elderly through increased bone resorption, with a resultant imbalance in bone remodeling.
引用
- Kim BJ, Hamrick MW, Yoo HJ, et al. The Detrimental Effects of Kynurenine, a Tryptophan Metabolite, on Human Bone Metabolism. J Clin Endocrinol Metab. 2019. PMID: 30715395. doi:10.1210/jc.2018-02481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。